High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi

Journal of Investigative Dermatology

Volumn 126, Issue 9, 2006, Pages 2111-2118

  Ichii Nakato, Nami ^a   Takata, Minoru ^a   Takayanagi, Shuko ^a   Takashima, Shiho ^a   Lin, Jingrong ^a   Murata, Hiroshi ^a   Fujimoto, Akihide ^b   Hatta, Naohito ^c   Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BRAF GENE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONGENITAL NEVUS; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENITAL SYSTEM; GLABROUS SKIN; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; MELANOCYTE; MELANOCYTIC NEVUS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; SUN EXPOSURE; ULTRAVIOLET RADIATION; CHILD; GENETIC SCREENING; GENETICS; INFANT; MICRODISSECTION; NEVUS; NUCLEOTIDE SEQUENCE; PATHOLOGY; POINT MUTATION; RADIATION EXPOSURE; SKIN; SUNLIGHT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; GENITALIA; HUMANS; INFANT; MALE; MELANOCYTES; MICRODISSECTION; NEVUS; POINT MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; SKIN; SUNLIGHT;

EID: 33746819361     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700366     Document Type: Article

References (41)

1. Abdel-Malek Z, Suzuki I, Tada A, Im S, Akcali C (1999) The melanocortin-1 receptor and human pigmentation. Ann NY Acad Sci 885:117-33
2. Archambault M, Yaar M, Gilchrest BA (1995) Keratinocytes and fibroblasts in a human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation. J Invest Dermatol 104:859-67
3. Bataille V (2003) Genetic epidemiology of melanoma. Eur J Cancer 39:1341-7
4. Bauer J, Garbe C (2003) Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 16:297-306
5. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-8
6. Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O et al. (2004) Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res 10:3444-7
7. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-54
8. Drobetsky EA, Turcotte J, Chateauneuf A (1995) A role for ultraviolet A in solar mutagenesis. Proc Natl Acad Sci USA 92:2350-4
9. Elder DE (1985) The blind men and the elephant. Different views of small congenital nevi. Arch Dermatol 121:1263-5
10. Elwood JM, Jopson J (1997) Melanoma and sun exposure: an overview of published studies. Int J Cancer 73:198-203
11. Gallagher RP, McLean DI (1995) The epidemiology of acquired melanocytic nevi. A brief review. Dermatol Clin 13:595-603
12. Green A (1992) A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Control 3:513-6
13. Gross S, Knebel A, Tenev T, Neininger A, Gaestel M, Herrlich P et al. (1999) Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction. J Biol Chem 274:26378-86
14. Harada M, Suzuki M, Ikeda T, Kaneko T, Harada S, Fukayama M (1997) Clonality in nevocellular nevus and melanoma: an expression-based clonality analysis at the X-linked genes by polymerase chain reaction. J Invest Dermatol 109:656-60
15. Houben R, Becker JC, Kappel A, Terheyden P, Brocker EB, Goetz R et al. (2004) Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis. J Carcinogen 3:6
16. Hui P, Perkins A, Glusac E (2001) Assessment of clonality in melanocytic nevi. J Cutan Pathol 28:140-4
17. Indsto JO, Cachia AR, Kefford RF, Mann GJ (2001) X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi. Clin Cancer Res 7:4054-9
18. Ishihara K, Saida T, Yamamoto A (2001) Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 6:109-16
19. Jhappan C, Noonan FP, Merlino G (2003) Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 22:3099-112
20. Kopf AW, Bart RS, Hennessey P (1979) Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1:123-30
21. Loewe R, Kittler H, Fischer G, Fae I, Wolff K, Petzelbauer P (2004) BRAF kinase gene V599E mutation in growing melanocytic lesions. J Invest Dermatol 123:733-6
22. Magana-Garcia M, Ackerman AB (1990) What are nevus cells? Am J Dermatopathol 12:93-102
23. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T et al. (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95:1878-90
24. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720-4
25. Miller CJ, Cheung M, Sharma A, Clarke L, Helm K, Mauger D et al. (2004) Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms. J Invest Dermatol 123:990-2
26. Papp T, Pemsel H, Zimmermann R, Bastrop R, Weiss DG, Schiffmann D (1999) Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi. J Med Genet 36:610-4
27. Papp T, Schipper H, Kumar K, Schiffmann D, Zimmermann R (2005) Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. Melanoma Res 15:401-7
28. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19-20
29. Raeve LE, Claes A, Ruiter DJ, Muijen GN, Roseeuw D, van Kempen LC (2006) Distinct phenotypic changes between the superficial and deep component of giant congenital melanocytic naevi: a rationale for curettage. Br J Dermatol 154:485-92
30. Rivers JK (2004) Is there more than one road to melanoma? Lancet 363:728-30
31. Robinson WA, Lemon M, Elefanty A, Harrison-Smith M, Markham N, Norris D (1998) Human acquired naevi are clonal. Melanoma Res 8:499-503
32. Saldanha G, Purnell D, Fletcher A, Potter L, Gillies A, Pringle JH (2004) High BRAF mutation frequency does not characterize all melanocytic tumor types. Int J Cancer 111:705-10
33. Sarasin A (1999) The molecular pathways of ultraviolet-induced carcinogenesis. Mutat Res 428:5-10
34. Shackelford W, Deng S, Murayama K, Wang J (2004) A new technology for mutation detection. Ann NY Acad Sci 1022:257-62
35. Tada A, Suzuki I, Im S, Davis MB, Cornelius J, Babcock G et al. (1998) Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ 9:575-84
36. Turner DJ, Zirvi MA, Barany F, Elenitsas R, Seykora J (2005) Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction. J Cutan Pathol 32:334-9
37. Uribe P, Wistuba II, Gonzalez S (2003) BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol 25:365-70
38. Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E et al. (2004) Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89:2867-72
39. Xing M (2005) BRAF mutation in thyroid cancer. Endocr Relat Cancer 12:245-62
40. Yazdi AS, Palmedo G, Flaig MJ, Puchta U, Reckwerth A, Rutten A et al. (2003) Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 121:1160-2
41. Zaal LH, Mooi WJ, Sillevis Smitt JH, van der Horst CM (2004) Classification of congenital melanocytic naevi and malignant transformation: a review of the literature. Br J Plast Surg 57:707-19